Risperidone in elderly schizophrenic patients - An open-label trial

被引：29
作者：
Berman, I [1 ]
Merson, A [1 ]
RachovPavlov, J [1 ]
Allan, E [1 ]
Davidson, M [1 ]
Losonczy, MF [1 ]
机构：
[1] HARVARD UNIV,SCH MED,CAMBRIDGE,MA 02138
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 1996年 / 4卷 / 02期
关键词：
D O I：
10.1097/00019442-199621420-00010
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The authors assessed the safety and efficacy of risperidone in a group of elderly, patients with chronic schizophrenia and behavioral disturbances (N = 10). There were no clinically significant changes on physical examination. Also, schizophrenic symptoms and cognitive performance improved during risperidone administration. Patients showed a sufficient improvement in both areas to warrant a larger, double-blind study assessing the effects of risperidone on cognitive and psychiatric symptoms in elderly psychotic patients.
引用
收藏
页码：173 / 179
页数：7
相关论文
共 50 条
  • [1] An open-label trial of risperidone in children with autism
    Diler, RS
    Firat, S
    Avci, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (01): : 91 - 102
  • [2] An Open-Label, Randomized, Controlled Trial of Zotepine and Risperidone for Acutely Ill, Hospitalized, Schizophrenic Patients With Symptoms of Agitation
    Chan, Hung-Yu
    Lin, An-Sheng
    Chen, Kun-Po
    Cheng, Jror-Serk
    Chen, Ying-Yeh
    Tsai, Chang-Jer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (06) : 747 - 752
  • [3] A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis
    Davidson, M
    Harvey, PD
    Vervarcke, J
    Gagiano, CA
    De Hooge, JD
    Bray, G
    Dose, M
    Barak, Y
    Haushofer, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (06) : 506 - 514
  • [4] An open-label trial of risperidone in children and adolescents with bipolar disorder
    Biederman, J
    Mick, E
    Wozniak, J
    Aleardi, M
    Spencer, T
    Faraone, SV
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (02) : 311 - 317
  • [5] An open-label trial of risperidone augmentation for refractory anxiety disorders
    Simon, NM
    Hoge, EA
    Fischmann, D
    Worthington, JJ
    Christian, KM
    Kinrys, G
    Pollack, MH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 381 - 385
  • [6] The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial
    Suzuki, Hidenobu
    Gen, Keishi
    Inoue, Yuichi
    Hibino, Hiroyuki
    Mikami, Ayako
    Matsumoto, Hideo
    Mikami, Katsunaka
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (01) : 58 - 62
  • [7] An Open-Label Trial of Risperidone in Children and Adolescents with Severe Mood Dysregulation
    Krieger, Fernanda Valle
    Pheula, Gabriel Ferreira
    Coelho, Roberta
    Zeni, Thamis
    Tramontina, Silza
    Zeni, Cristian Patrick
    Rohde, Luis Augusto
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (03) : 237 - 243
  • [8] Risperidone in the treatment of delirium: Results from a prospective open-label trial
    Mittal, D
    Jimerson, NA
    Neely, EP
    Johnson, WD
    Kennedy, RE
    Torres, RA
    Nasrallah, HA
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (05) : 662 - 667
  • [9] Treatment of delirium with risperidone: Results from an open-label prospective trial
    Mittal, D
    Jimerson, N
    Peoples, E
    Johnson, W
    Kennedy, R
    Torres, R
    Nasrallah, H
    PSYCHOSOMATICS, 2003, 44 (02) : 139 - 140
  • [10] Long-term treatment of psychotic patients with risperidone. An open-label multicentre trial
    Kocmur, M
    Tavcar, R
    Dernovsek, MZ
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 199 - 199
12345